Evidence map›Paper›PMID 36747263›Full record

ArticleJournal of nanobiotechnology2023

Novel opto-fluidic drug delivery system for efficient cellular transfection.

Majid Layachi, Anthony Treizebré, Laurent Hay, David Gilbert, Jean Pesez, Quentin D'Acremont, Kevin Braeckmans, Quentin Thommen, Emmanuel Courtade

Open access · goldAbstract read
In one paragraph

Article in Journal of nanobiotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Majid LayachiLaboratoire Physique des Lasers, Atomes et Molécules - UMR 8523, Université de Lille, 59655, Villeneuve d'Ascq, France.
Anthony TreizebréLaboratoire Physique des Lasers, Atomes et Molécules - UMR 8523, Université de Lille, 59655, Villeneuve d'Ascq, France.
Laurent HayLaboratoire Physique des Lasers, Atomes et Molécules - UMR 8523, Université de Lille, 59655, Villeneuve d'Ascq, France.
David GilbertLaboratoire Physique des Lasers, Atomes et Molécules - UMR 8523, Université de Lille, 59655, Villeneuve d'Ascq, France.
Jean PesezLaboratoire Physique des Lasers, Atomes et Molécules - UMR 8523, Université de Lille, 59655, Villeneuve d'Ascq, France.
Quentin D'AcremontLaboratoire Physique des Lasers, Atomes et Molécules - UMR 8523, Université de Lille, 59655, Villeneuve d'Ascq, France.
Kevin BraeckmansLaboratory for General Biochemistry and Physical Pharmacy, Ghent University, 9000, Ghent, Belgium.ORCID http://orcid.org/0000-0002-7993-6295
Quentin ThommenCANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies - UMR9020-UMR1277, Université de Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, 59000, Lille, France.
Emmanuel CourtadeLaboratoire Physique des Lasers, Atomes et Molécules - UMR 8523, Université de Lille, 59655, Villeneuve d'Ascq, France. emmanuel.courtade@univ-lille.fr.ORCID http://orcid.org/0000-0002-2748-7643
Laboratoire de Physique des Lasers, Atomes et Molécules · FRCentre National de la Recherche Scientifique · FRGhent University Hospital · BE

Funding

ERC Consolidator grant NANOBUBBLE (2014)LABEX CEMPI ANR-11-LABX- 0007Ministry of Higher Education and Research, Hauts de France council and European Regional Development Fund (ERDF) CPER Photonics for Society P4S
6 · The paper itself

Abstract

Intracellular drug delivery is at the heart of many diagnosis procedures and a key step in gene therapy. Research has been conducted to bypass cell barriers for controlled intracellular drug release and made consistent progress. However, state-of-the-art techniques based on non-viral carriers or physical methods suffer several drawbacks, including limited delivery yield, low throughput or low viability, which are key parameters in therapeutics, diagnostics and drug delivery. Nevertheless, gold nanoparticle (AuNP) mediated photoporation has stood out as a promising approach to permeabilize cell membranes through laser induced Vapour NanoBubble (VNB) generation, allowing the influx of external cargo molecules into cells. However, its use as a transfection technology for the genetic manipulation of therapeutic cells is hindered by the presence of non-degradable gold nanoparticles. Here, we report a new optofluidic method bringing gold nanoparticles in close proximity to cells for photoporation, while avoiding direct contact with cells by taking advantage of hydrodynamic focusing in a multi-flow device. Cells were successfully photoporated with [Formula: see text] efficiency with no significant reduction in cell viability at a throughput ranging from [Formula: see text] to [Formula: see text]. This optofluidic approach provides prospects of translating photoporation from an R &D setting to clinical use for producing genetically engineered therapeutic cells.

Indexed as

GoldMetal NanoparticlesDrug Delivery SystemsHumansPharmaceutical PreparationsTransfectionGoldPharmaceutical PreparationsHigh-throughput intracellular deliveryMicrofluidicsNanoparticle micro-positioningPhotoporationVapour nanobubbles

Identifiers

PMID36747263
PMCPMC9901003
OpenAlexW4319320263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.